Lupin (NSE:LUPIN) Short-Term Debt : ₹26,699 Mil (As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Lupin Short-Term Debt?

Lupin's Short-Term Debt for the quarter that ended in Mar. 2024 was ₹26,699 Mil.

Lupin's quarterly Short-Term Debt declined from Sep. 2023 (₹35,237 Mil) to Dec. 2023 (₹0 Mil) but then increased from Dec. 2023 (₹0 Mil) to Mar. 2024 (₹26,699 Mil).

Lupin's annual Short-Term Debt increased from Mar. 2022 (₹37,023 Mil) to Mar. 2023 (₹42,165 Mil) but then declined from Mar. 2023 (₹42,165 Mil) to Mar. 2024 (₹26,699 Mil).

Lupin Short-Term Debt Historical Data

The historical data trend for Lupin's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lupin Short-Term Debt Chart

Lupin Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Short-Term Debt

Get a 7-Day Free Trial

45,120.40

47,668.60

37,023.00

42,165.40

26,699.10

Lupin Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Debt	Get a 7-Day Free Trial															42,165.40	-	35,237.40	-	26,699.10

Lupin Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Lupin Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Lupin's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Lupin (NSE:LUPIN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lupin Ltd (NSE:LUPIN) » Definitions » Short-Term Debt

Traded in Other Exchanges

500257:India

Address

Off. Western Express Highway, 3rd floor, Kalpataru Inspire, Santacruz (East), Mumbai, MH, IND, 400 055

Website

https://www.lupin.com

Lupin Ltd is a specialty and generic drug manufacturing company. The company's global formulations business develops and delivers a wide range of branded and generic formulations across the globe. The operations of the company are limited to one segment, namely pharmaceuticals and related products. The company also maintains a pipeline in high-barrier markets such as Inhalation, Biosimilars and Complex Injectables. The vast majority of the company's sales are generated in the United States, followed by India.

Lupin (NSE:LUPIN) Headlines

No Headlines